Dokument
| Titel: | Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Cervical Cancer Screening in Gynecological Practices in Germany |
| Autor: | Gremke, Niklas |
| Weitere Verfasser: | Griewing, Sebastian; Felgentreff, Markus; Kostev, Karel; Kalder, Matthias |
| Veröffentlicht: | 2022 |
| URI: | https://archiv.ub.uni-marburg.de/es/2023/0066 |
| URN: | urn:nbn:de:hebis:04-es2023-00667 |
| DOI: | https://doi.org/10.3390/cancers14194820 |
| DDC: | 610 Medizin |
| Publikationsdatum: | 2023-05-16 |
| Lizenz: | https://creativecommons.org/licenses/by/4.0 |
| Schlagwörter: |
|---|
| gynecological practices, COVID-19 pandemic, Germany, cervical cancer, screening |
Summary:
The outbreak of the coronavirus disease 2019 (COVID-19) is a major challenge for healthcare systems and impedes cancer screening programs worldwide. However, no research has been performed that analyzes the effects of the COVID-19 pandemic on the newly implemented German Cervical Cancer Screening (CCS) program. Here, we showed a severe clinically relevant decrease of patients receiving CCS in Germany between the pre-pandemic time period of 2018–2019 and the pandemic years of 2020–2021. Given that this sudden drop in number of CCS per practice is unlikely, our data suggest a dramatic number of underdiagnosed cervical precancer lesions that may lead to increased cervical cancer burden in the future.
 | Das Dokument ist im Internet frei zugänglich - Hinweise zu den Nutzungsrechten |